SBIR/STTR Research Award
OTHER FUNCTIONS: SBIR PHASE I, MED. ADHERENCE IN HIGHER RISK POPULATIONS, N43DA-12-2227, BASE AWARD.
Award amount
$137,921Program and phase
SBIR · Phase IAward year
2012Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- AICURE, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- VZBHVD36W5D5
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
AI Cure Technologies seeks to develop and test the effectiveness and usability of AiView-HR, an automated, population-based medication adherence monitoring system for high-risk, substance abuse populations. AiView-HR will be a significant extension of Ai Cure Technologies' flagship computer-vision product, AiView, incorporating enhanced security sequence elements that will be critical to deploying automated DOT (directly observed therapy) to the high-risk, substance abuse population. Like AiView, AiView-HRwill be coupled with a robust web-based dashboard that enables efficient population-based or individual monitoring, review, and intervention of medication adherence.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Funding of Phase II SBIR Contract. N44 DA-12-2227
- Automating Directly Observed Therapy as a Platform Technology
- Fractal Identification System for Medication
- Gesture Based Medication Adherence Confirmation for Clinical Trials
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
5 SBIR/STTR records share this UEI (2011–2013). Reported award amounts total $3,419,899. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services